Pharmaceutical & life sciences

Pharmaceutical Artwork Management Systems & Services

Pharmaceutical artwork is regulated content. Labels, leaflets, IFUs and cartons change frequently, across many markets, under strict control. This page explains what to look for — and what to verify before trusting any claim.

Artwork types
Labels, leaflets, IFUs, cartons, components
Key need
Controlled change with a complete audit trail
Complication
Multi-market regulatory variation
Before matching
Requirements qualified in detail

Why pharmaceutical artwork is different

In pharmaceuticals and wider life sciences, artwork is part of the regulated product. Changes are driven by regulatory submissions, safety updates, site transfers and market launches, and each must be implemented accurately across every affected component.

Organisations typically need controlled approval, strong version control, a complete audit trail and — in many cases — evidence that the systems used are appropriate for their quality management system. Requirements differ significantly by organisation, product and market.

Not every artwork provider is suitable for pharmaceutical work, and not every system is validated for that use. We qualify requirements explicitly before matching and do not assume any provider meets them.

Who this is for

  • Pharmaceutical manufacturers and marketing authorisation holders
  • Generic and consumer healthcare companies with large portfolios
  • Medical device and diagnostics manufacturers managing IFUs and labels
  • Contract manufacturers and packagers handling client artwork

Common pain points

  • Regulatory changes that must reach many components and markets by a deadline
  • Leaflet and label text that must match approved source documents exactly
  • Fragmented approvals between regulatory, QA, medical and supply chain
  • Difficulty assembling evidence of approval for inspection
  • Artwork change volume outpacing internal resource

A controlled artwork change

  1. 01

    Change initiation

    Change request linked to its regulatory or quality trigger and affected components identified.

  2. 02

    Content control

    Text taken from approved source documents; translations controlled.

  3. 03

    Production and proofing

    Artwork produced and checked against source, often with text comparison tools.

  4. 04

    Approval and release

    Defined approvers sign off; approved artwork released with full history.

Capabilities to qualify

Treat each as a question for providers, not an assumption.

Controlled approval
Defined roles and sign-off captured per version.
Audit trails
Complete, tamper-evident history of changes and decisions.
Versioning
Every version retained and comparable.
Structured content
Controlled reuse of approved text across components and markets.
Validation
Whether the provider supports validation of the system for your intended use, and what documentation exists.
Multi-market changes
Handling of country-specific content and languages.
Component coverage
Labels, leaflets, IFUs, cartons, foils and other components.

What we ask before matching providers

  • Which artwork components and markets are in scope?
  • What does your quality system require of artwork systems and suppliers?
  • Is system validation required, and who will perform it?
  • Are you seeking software, managed artwork services or both?
  • Which existing systems (RIM, QMS, ERP, DAM) must connect?

Software, managed service or hybrid?

Most organisations evaluating this category are really choosing between three operating models. The right one depends on volume, in-house capacity and how much control you need over the workflow.

Artwork management softwareManaged artwork productionHybrid
Who does the artwork workYour team or your agenciesAn external production providerProvider produces; your team controls workflow and approval
What you buyPlatform licence, set-up and supportProduction capacity, usually per job or retained volumePlatform plus production capacity
Best fitStable in-house team, need for control and visibilityLimited internal capacity, seasonal or rising volumeHigh volume with strict governance requirements
Main riskAdoption and configuration effortDependency on one supplier, briefing qualityMore moving parts to contract and manage
Typical question to resolveWhich workflow and integrations are essential?What turnaround and quality controls are guaranteed?Who owns the system, the data and the approval record?

Selection considerations

  • Ask for sector references of comparable size and scope
  • Request documentation supporting validation claims and review it with QA
  • Test text comparison on real leaflets and multi-language artwork
  • Clarify responsibilities between provider and your quality system

Questions to ask providers

  • What documentation do you provide to support system validation?
  • Which pharmaceutical or life-sciences organisations can act as references?
  • How are electronic approvals captured and secured?
  • How do you handle leaflets and multi-language components?

Use cases

Safety-driven label updates

Implementing safety text changes across every affected component and market.

Site or supplier transfers

Updating manufacturer and packaging details across a portfolio.

Portfolio acquisition

Bringing acquired products' artwork under your own control.

Managed artwork services

Outsourcing production while retaining internal approval.

Implementation considerations

Implementation in a regulated environment usually involves quality, IT and regulatory stakeholders from the start. Validation planning, data migration and procedure updates can take significant time.

Hybrid models — a provider producing artwork within your controlled system, or within theirs under agreed controls — are common. Responsibilities must be clearly defined contractually.

Frequently asked questions

Are all artwork management systems suitable for pharma?

No. Suitability depends on your quality system, intended use and the provider's controls and documentation. We qualify these requirements before any introduction.

Can you tell us which regulations apply?

We do not provide regulatory advice. Requirements should be confirmed by your regulatory and quality teams.

Requirements assessment

Discuss your pharmaceutical artwork workflow

Tell us about your components, markets and quality requirements. We will review them before suggesting any provider.